Pharmaceutical Supply of Miconazole Nitrate

The contract seeks the supply of Miconazole Nitrate in either bulk active pharmaceutical ingredient or finished dosage form, adhering strictly to FDA current Good Manufacturing Practices and Department of Defense-specific labeling and packaging standards. All products must meet military packaging requirements to ensure compatibility with defense logistics systems and field deployment conditions. The procurement is managed under the Medical Supply Chain Pharm FSA, operating within the Department of Defense, with performance centered at Fort Lee, Virginia, 23801. The facility must be fully compliant with cGMP standards and capable of delivering product that aligns with DLA labeling specifications to support military medical operations. This is a subcontract opportunity with a response deadline of May 5, 2026, and is classified under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The solicitation does not specify a set-aside designation and is open to qualified suppliers with demonstrated capability in producing pharmaceuticals for government and defense applications. All submissions must be made through the DIBBS portal using the provided reference number SPE2DP26T3180, and vendors are expected to demonstrate proven experience with high-volume, regulated pharmaceutical manufacturing for federal procurement.